International Urology and Nephrology

, Volume 44, Issue 1, pp 323–325 | Cite as

Aspirin resistance in hemodialysis patients

  • Abdallah Sassine Geara
  • Nassif Azzi
  • Claude Bassil
  • Suzanne El-Sayegh
Nephrology – Letter to the Editor



All authors have no financial support or conflicts of interest to report.


  1. 1.
    Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR (2008) Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 336:195–198PubMedCrossRefGoogle Scholar
  2. 2.
    Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S (2008) Assessing the current role of platelet function testing. Clin Cardiol 31:I10–I16PubMedCrossRefGoogle Scholar
  3. 3.
    Chen WH, Lee PY, Ng W, Kwok JY, Cheng X, Lee SW, Tse HF, Lau CP (2005) Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary intervention. Am J Cardiol 96:760–763PubMedCrossRefGoogle Scholar
  4. 4.
    Chen WH, Lee PY, Ng W, Tse HF, Lau CP (2004) Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43:1122–1126PubMedCrossRefGoogle Scholar
  5. 5.
    Dyszkiewicz-Korpanty AM, Kim A, Burner JD, Frenkel EP, Sarode R (2007) Comparison of a rapid platelet function assay–Verify Now Aspirin–with whole blood impedance aggregometry for the detection of aspirin resistance. Thromb Res 120:485–488PubMedCrossRefGoogle Scholar
  6. 6.
    Polkinghorne K (2008) The CARI guidelines Pharmacological approaches to preventing vascular access failure. Nephrology (Carlton) 13(Suppl 2):S12–S16CrossRefGoogle Scholar
  7. 7.
    Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, Ando Y, Nitta K (2010) Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol 42:187–194PubMedCrossRefGoogle Scholar
  8. 8.
    Acikel S, Yildirir A, Aydinalp A, Demirtas K, Bal U, Kaynar G, Ozin B, Karakayali H, Muderrisoglu H, Haberal M (2008) Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients. Transplant Proc 40:3485–3488PubMedCrossRefGoogle Scholar
  9. 9.
    Hankey GJ, Eikelboom JW (2006) Aspirin resistance. Lancet 367:606–617PubMedCrossRefGoogle Scholar
  10. 10.
    Gasparyan AY, Watson T, Lip GY (2008) The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 51:1829–1843PubMedCrossRefGoogle Scholar
  11. 11.
    Bloom A, Greaves M, Preston FE, Brown CB (1986) Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis. Br J Haematol 62:143–149PubMedCrossRefGoogle Scholar
  12. 12.
    Cavarape A, Bauer J, Bartoli E, Endlich K, Parekh N (2003) Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant 18:1764–1769PubMedCrossRefGoogle Scholar
  13. 13.
    Spurney RF, Fan PY, Ruiz P, Sanfilippo F, Pisetsky DS, Coffman TM (1992) Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Int 41:973–982PubMedCrossRefGoogle Scholar
  14. 14.
    Lianos EA, Andres GA, Dunn MJ (1983) Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics. J Clin Invest 72:1439–1448PubMedCrossRefGoogle Scholar
  15. 15.
    Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R (2009) Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 30:426–435PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2010

Authors and Affiliations

  • Abdallah Sassine Geara
    • 1
  • Nassif Azzi
    • 2
  • Claude Bassil
    • 2
  • Suzanne El-Sayegh
    • 3
  1. 1.Nephrology DepartmentNew York Presbyterian HospitalNew YorkUSA
  2. 2.Department of Internal MedicineStaten Island University HospitalStaten IslandUSA
  3. 3.Nephrology DivisionStaten Island University HospitalStaten IslandUSA

Personalised recommendations